Related Experiment Video
Updated: Jun 6, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Update on pediatric psoriasis, Part 2: Therapeutic management
1Pediatric and Adolescent Dermatology, St. Luke's-Roosevelt Hospital Center, 1090 Amsterdam Ave, Ste 11D, New York, NY 10025, USA. nsilverb@chpnet.org
Insights
Pediatric psoriasis, an autoimmune condition, requires prompt treatment to mitigate psychological effects in children. Management strategies vary based on disease severity and joint involvement.
Area of Science:
- Immunology
- Dermatology
- Pediatrics
Background:
- Pediatric psoriasis is an autoimmune disorder with complex immunologic underpinnings.
- It is frequently linked to significant psychological distress in affected children.
- Upper respiratory tract infections are a common trigger for childhood psoriasis.
Purpose of the Study:
- To outline the management of pediatric psoriasis.
- To emphasize the importance of addressing psychological morbidity in children with psoriasis.
- To review current and emerging treatment options.
Main Methods:
- Treatment selection is guided by disease severity and the presence of joint involvement.
- Topical treatments include corticosteroids and calcipotriene.
- Systemic therapies such as UV light, retinoids, cyclosporine, methotrexate, and etanercept are employed.
Main Results:
- Various therapeutic agents effectively manage cutaneous psoriatic lesions.
- Methotrexate sodium and etanercept demonstrate efficacy in treating both skin and joint manifestations.
- Prompt and effective treatment is crucial for limiting psychologic effects.
Conclusions:
- Effective management of pediatric psoriasis necessitates a comprehensive approach.
- Addressing psychological symptoms and supporting psychological growth is vital.
- Treatment strategies should be tailored to individual patient needs, considering disease severity and comorbidities.
Abstract:
Pediatric psoriasis is an autoimmune diathesis with a complex immunologic basis. It is associated with extensive psychological morbidity and should be treated rapidly and effectively to limit psychologic effects on children. The most common trigger in childhood is upper respiratory tract infection. Once disease has occurred, treatment is based on severity and presence of joint involvement. Topical therapies include corticosteroids and calcipotriene. UV light, systemic retinoids, and cyclosporine remit cutaneous psoriatic lesions. Methotrexate sodium and etanercept benefit both skin and joint manifestations of psoriasis. Concern for psychological symptoms and psychological growth is needed in treating pediatric patients with psoriasis vulgaris.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drug Therapy
Antianxiety Medications
Nephrotic Syndrome II : Assessment and Medical Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acne Infection